226 related articles for article (PubMed ID: 25249355)
1. Prompt diagnosis and effective treatment of Trichosporon asahii catheter-related infection in non-immunocompromised neurosurgical patient.
Rubic Z; Novak A; Tomic Z; Goic-Barisic I; Radic M; Tonkic M
Mycopathologia; 2015 Feb; 179(1-2):125-8. PubMed ID: 25249355
[TBL] [Abstract][Full Text] [Related]
2. Disseminated Trichosporon asahii infection in a combined liver-kidney transplant recipient successfully treated with voriconazole.
Sah R; Soin AS; Chawla S; Wadhwa T; Gupta N
Immun Inflamm Dis; 2019 Sep; 7(3):125-129. PubMed ID: 31006179
[TBL] [Abstract][Full Text] [Related]
3. [Nosocomial infection due to Trichosporon asahii in a critical burned patient].
Tamayo Lomas L; Domínguez-Gil González M; Martín Luengo AI; Eiros Bouza JM; Piqueras Pérez JM
Rev Iberoam Micol; 2015; 32(4):257-60. PubMed ID: 25579090
[TBL] [Abstract][Full Text] [Related]
4. Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system.
Treviño M; García-Riestra C; Areses P; García X; Navarro D; Suárez FJ; López-Dequidt IA; Zaragoza O; Cuenca-Estrella M
Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1497-503. PubMed ID: 24718613
[TBL] [Abstract][Full Text] [Related]
5. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Sun W; Su J; Xu S; Yan D
J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
[TBL] [Abstract][Full Text] [Related]
6. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
[TBL] [Abstract][Full Text] [Related]
7. Exploring the resistance mechanisms in Trichosporon asahii: Triazoles as the last defense for invasive trichosporonosis.
Padovan ACB; Rocha WPDS; Toti ACM; Freitas de Jesus DF; Chaves GM; Colombo AL
Fungal Genet Biol; 2019 Dec; 133():103267. PubMed ID: 31513917
[TBL] [Abstract][Full Text] [Related]
8. Isolation and antifungal susceptibility testing of Trichosporon asahii in Ceará, Brazil.
Menezes EA; Marinho JA; Angelo MR; Cunha Mda C; Cunha FA; Vasconcelos Júnior AA
Rev Inst Med Trop Sao Paulo; 2012; 54(1):1-3. PubMed ID: 22370746
[TBL] [Abstract][Full Text] [Related]
9. Trichosporon asahii causing subcutaneous mycoses in an immunocompetent patient: case report and a minireview.
Kruschewsky WLL; Massaroni-Peçanha P; Maifrede SB; Leite MS; Pôssa TAL; Alberto-Lei F; Cayô R; Peçanha PM; Gonçalves SS
Braz J Microbiol; 2022 Sep; 53(3):1221-1229. PubMed ID: 35378689
[TBL] [Abstract][Full Text] [Related]
10. Trichosporon asahii infection presenting as chronic meningo-ventriculitis and intra ventricular fungal ball: a case report and literature review.
Kumar A; Udayakumaran S; Babu R; Rajamma BM; Prakash A; Panikar D; Karim S; Chowdhary A
Mycoses; 2015 Feb; 58(2):99-103. PubMed ID: 25590228
[TBL] [Abstract][Full Text] [Related]
11. Possible Trichosporon asahii urinary tract infection in a critically ill COVID-19 patient.
Vianello M; Jesus DFF; Sampaio JM; de Oliveira GM; Lincopan N; Ishida K
Rev Iberoam Micol; 2022; 39(2):54-56. PubMed ID: 35788316
[TBL] [Abstract][Full Text] [Related]
12. Emerging pan-resistance in Trichosporon species: a case report.
Oliveira dos Santos C; Zijlstra JG; Porte RJ; Kampinga GA; van Diepeningen AD; Sinha B; Bathoorn E
BMC Infect Dis; 2016 Apr; 16():148. PubMed ID: 27074951
[TBL] [Abstract][Full Text] [Related]
13. Chemoport-related Fungemia Caused by Trichosporon asahii.
Raju DS; Sugunan A; Keechilattu P; Philip A; Reghu R
J Pediatr Hematol Oncol; 2020 Apr; 42(3):e193-e194. PubMed ID: 30676435
[TBL] [Abstract][Full Text] [Related]
14. A rare case of urinary tract infection due to Trichosporon asahii in a diabetic patient.
Iken M; Belkouch A; Bellarj B; Naoui H; Boumhil L; El Bouti A; Jidane S; Belyamani L; Lmimouni B
Pan Afr Med J; 2015; 20():127. PubMed ID: 26097631
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and Antifungal Susceptibility of Infections Caused by
Singh S; Capoor MR; Varshney S; Gupta DK; Verma PK; Ramesh V
Indian J Med Microbiol; 2019; 37(4):536-541. PubMed ID: 32436877
[TBL] [Abstract][Full Text] [Related]
16. Trichosporon inkin meningitis in Northeast Brazil: first case report and review of the literature.
Milan EP; Silva-Rocha WP; de Almeida JJS; Fernandes TUG; de Araújo Prudente AL; de Azevedo MF; Francisco EC; de Azevedo Melo AS; Colombo AL; Chaves GM
BMC Infect Dis; 2018 Sep; 18(1):470. PubMed ID: 30227852
[TBL] [Abstract][Full Text] [Related]
17. MALDI-TOF MS characterisation, genetic diversity and antifungal susceptibility of Trichosporon species from Iranian clinical samples.
Ahangarkani F; Ilkit M; Vaseghi N; Zahedi N; Zomorodian K; Khodavaisy S; Afsarian MH; Abbasi K; de Groot T; Meis JF; Badali H
Mycoses; 2021 Aug; 64(8):918-925. PubMed ID: 33998718
[TBL] [Abstract][Full Text] [Related]
18. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients.
Xia Z; Yang R; Wang W; Cong L
Mycopathologia; 2012 Mar; 173(2-3):127-33. PubMed ID: 21979867
[TBL] [Abstract][Full Text] [Related]
19. Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
Ramírez I; Moncada D
Mycopathologia; 2020 Apr; 185(2):377-388. PubMed ID: 31853871
[TBL] [Abstract][Full Text] [Related]
20. A case report of catheter-related bloodstream infection due to Trichosporon coremiiforme in a patient with secondary neutropenia to HIV.
Monzani V; Córdoba S; Vivot M; Arias B; Vivot W; Szusz W; Castellaro P; Appendino A; Taverna CG
J Mycol Med; 2020 Apr; 30(1):100916. PubMed ID: 31843296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
